JNJ-10229570
目录号: PL07058 纯度: ≥98.0%
CAS No. :524923-88-4
商品编号 规格 价格 会员价 是否有货 数量
PL07058-5mg 5mg ¥3585.45 请登录
PL07058-10mg 10mg ¥5563.64 请登录
PL07058-25mg 25mg ¥11992.73 请登录
PL07058-50mg 50mg ¥14836.36 请登录
PL07058-100mg 100mg 询价 询价
PL07058-200mg 200mg 询价 询价
PL07058-10mM*1mLinDMSO 10mM*1mLinDMSO ¥3944.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
JNJ-10229570
中文别名
2,3-bis(2-methoxyphenyl)-N-phenyl-1,2,4-thiadiazol-5-imine
英文名称
JNJ-10229570
英文别名
JNJ-10229570;JNJ 10229570;N9IX402L35;JNJ10229570;Benzenamine, N-(2,3-bis(2-methoxyphenyl)-1,2,4-thiadiazol-5(2H)-ylidene)-;2,3-bis(2-methoxyphenyl)-N-phenyl-1,2,4-thiadiazol-5-imine;BCP30848;ZVA92388;A16876;N16878;JNJ10229570; JNJ 10229570;Q27284735;2,3-Bis(2-methoxyphenyl)-N-phenyl-1,2,4-thiadiazol-5(2H)-imine
Cas No.
524923-88-4
分子式
C22H19N3O2S
分子量
389.47
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
JNJ-10229570 是肾上腺皮质受体 1 (MC1R) 和肾上腺皮质受体 5 (MC5R) 的拮抗剂,可抑制皮脂腺分化和皮质特异性脂质的产生,其抑制 125I-NDP-α-MSH 和人类细胞中 MC1R 和 MC5R 结合的 IC50 值分别为 270 nM 和 200 nM。
生物活性
JNJ-10229570 is an antagonist of melanocortin receptor 1 (MC1R) and melanocortin receptor 5 (MC5R), which inhibits sebaceous gland differentiation and the production of sebum-specific lipids. JNJ-10229570 inhibits the binding of I-NDP-α-MSH to cells expressing human MC1R and MC5R, with IC 50 values of 270 nM and 200 nM, respectively.
性状
Solid
IC50 & Target[1][2]
IC50: 270 nM (human MC1R), 200 nM (human MC5R).
体外研究(In Vitro)
JNJ-10229570 dose dependently inhibits the production of sebaceous lipids in cultured primary human sebocytes. JNJ-7818369 inhibits the binding of I-NDP-α-MSH to cells expressing human MC1R and MC5R, with IC50s of 270±120 and 200±50 nM, respectively. Nearly-identical results are obtained with the free base form of the compound. Binding to MC4R of both forms of the compound is equipotent, with IC50s of 240±170 nM. JNJ-10229570-treated cells show strong inhibition of lipid granules at 0.01 μM, and complete inhibition at 0.05 μM. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Topical treatment with JNJ-10229570 of human skins transplanted onto SCID mice result in a marked decrease in sebum-specific lipid production, sebaceous glands size and the expression of the sebaceous differentiation marker epithelial-membrane antigen (EMA). Topical treatment with 0.05% JNJ-10229570 leads to a distinct reduction in both the steady-state and the newly-synthesized sebum-specific lipids, with lesser effects on triglycerides and cholesterol. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Eisinger M, et al. A melanocortin receptor 1 and 5 antagonist inhibits sebaceous gland differentiation and the production of sebum-specific lipids. J Dermatol Sci. 2011 Jul;63(1):23-32.
溶解度数据
In Vitro: DMSO : 62.5 mg/mL (160.47 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2